BeiGene, Ltd. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BeiGene, Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2024.
  • BeiGene, Ltd. Operating Income (Loss) for the quarter ending September 30, 2024 was -$120M, a 10.2% increase year-over-year.
  • BeiGene, Ltd. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$873M, a 32.5% increase year-over-year.
  • BeiGene, Ltd. annual Operating Income (Loss) for 2023 was -$1.21B, a 32.5% increase from 2022.
  • BeiGene, Ltd. annual Operating Income (Loss) for 2022 was -$1.79B, a 24.4% decline from 2021.
  • BeiGene, Ltd. annual Operating Income (Loss) for 2021 was -$1.44B, a 13.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$873M -$120M +$13.7M +10.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$886M -$107M +$212M +66.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$1.1B -$261M +$110M +29.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$1.21B -$384M +$84.8M +18.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$1.29B -$134M +$304M +69.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$1.6B -$319M +$121M +27.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$1.72B -$371M +$72M +16.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$1.79B -$469M +$103M +18% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$1.89B -$438M +$24M +5.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.92B -$439M +$35.4M +7.46% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$1.95B -$443M -$513M -732% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$1.44B -$572M -$86.8M -17.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$1.35B -$462M -$22.2M -5.04% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.33B -$475M -$116M -32.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$1.21B $70.2M +$444M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$1.66B -$485M -$96.9M -25% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$1.56B -$440M -$128M -40.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.43B -$359M -$273M -318% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$1.16B -$374M -$200M -115% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$960M -$388M -$107M -38.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$853M -$312M -$161M -107% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$691M -$85.8M +$77.2M +47.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$769M -$174M -$62.9M -56.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$706M -$281M -$177M -171% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$529M -$151M -$266M -232% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$263M -$163M -$105M -181% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$158M -$111M -$59.3M -115% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$98.5M -$104M -$66.5M -179% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$31.9M $115M +$150M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$182M -$58M -$33.4M -136% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$148M -$51.5M -$31.2M -153% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$117M -$37.3M -$10.9M -41.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 -$106M -$34.8M -$20.8M -149% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 -$85.3M -$24.6M -$18.1M -275% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 -$67.3M -$20.3M -$10.5M -107% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 -$56.7M -$26.4M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$14M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-22
Q2 2015 -$6.57M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-22
Q1 2015 -$9.81M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.